ZL-1211 exhibits robust anti-tumor activity by enhancing ADCC and activating innate and adaptive immunity in CLDN18.2-high and-low expressing gastric cancer models

被引：0

|

作者：

Konno, Hiroyasu ^{[1
]}

Lin, Tracey ^{[1
]}

Sun, Bee-Chun ^{[1
]}

Wu, Renyi ^{[1
]}

Szeto, Christopher ^{[1
]}

Bellovin, David ^{[1
]}

Hsu, Karl ^{[1
]}

Kabbarah, Omar ^{[1
]}

机构：

[1] Zai Lab US LLC, Menlo Pk, CA USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

621

引用

收藏

页数：1

相关论文

共 2 条

[1] ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell-mediated Inflammation in CLDN18.2-High and-Low Expressing Gastric Cancer Models
Konno, Hiroyasu
Lin, Tracey
Wu, Renyi
Dai, Xinchuan
Li, Shou
Wang, Grace
Chen, Min
Li, Wenying
Wang, Lina
Sun, Bee-Chun
Luo, Zhen
Huang, Tom
Chen, Yuping
Zhang, John
Ye, Qiuping
Bellovin, David
Wan, Bing
Kang, Lishan
Szeto, Christopher
Hsu, Karl
Kabbarah, Omar
CANCER RESEARCH COMMUNICATIONS, 2022, 2 (09): : 937 - 950
[2] ZL-1211 exhibits broad anti-tumor activity in CLDN18.2 high- and low-expressing models.
Konno, Hiroyasu
Li, Yong
Dai, Xinchuan
Sun, Bee
Shi, Wenhua
Chen, Min
Li, Wenying
Li, Shou
Kang, Lishan
Li, Holly
Tao, Frank
Yin, Sophia
Wang, Bingbing
Shan, Lishen
Wan, Bing
Veiby, Petter
Yan, James
Hsu, Karl
Bellovin, David
Kabbarah, Omar
CANCER RESEARCH, 2021, 81 (13)